Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 11 |
GO:0043226 | organelle | 2 | 11 |
GO:0043227 | membrane-bounded organelle | 3 | 11 |
GO:0043229 | intracellular organelle | 3 | 11 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 11 |
GO:0110165 | cellular anatomical entity | 1 | 11 |
GO:0030896 | checkpoint clamp complex | 3 | 1 |
GO:0032991 | protein-containing complex | 1 | 1 |
GO:0140513 | nuclear protein-containing complex | 2 | 1 |
Related structures:
AlphaFold database: E9AI98
Term | Name | Level | Count |
---|---|---|---|
GO:0000075 | cell cycle checkpoint signaling | 4 | 11 |
GO:0000077 | DNA damage checkpoint signaling | 5 | 11 |
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 11 |
GO:0006259 | DNA metabolic process | 4 | 11 |
GO:0006281 | DNA repair | 5 | 11 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 11 |
GO:0006807 | nitrogen compound metabolic process | 2 | 11 |
GO:0006950 | response to stress | 2 | 11 |
GO:0006974 | DNA damage response | 4 | 11 |
GO:0007165 | signal transduction | 2 | 11 |
GO:0008152 | metabolic process | 1 | 11 |
GO:0009987 | cellular process | 1 | 11 |
GO:0010564 | regulation of cell cycle process | 5 | 11 |
GO:0010948 | negative regulation of cell cycle process | 6 | 11 |
GO:0031570 | DNA integrity checkpoint signaling | 5 | 11 |
GO:0033554 | cellular response to stress | 3 | 11 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 11 |
GO:0035556 | intracellular signal transduction | 3 | 11 |
GO:0042770 | signal transduction in response to DNA damage | 4 | 11 |
GO:0043170 | macromolecule metabolic process | 3 | 11 |
GO:0044237 | cellular metabolic process | 2 | 11 |
GO:0044238 | primary metabolic process | 2 | 11 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 11 |
GO:0045786 | negative regulation of cell cycle | 5 | 11 |
GO:0046483 | heterocycle metabolic process | 3 | 11 |
GO:0048519 | negative regulation of biological process | 3 | 11 |
GO:0048523 | negative regulation of cellular process | 4 | 11 |
GO:0050789 | regulation of biological process | 2 | 11 |
GO:0050794 | regulation of cellular process | 3 | 11 |
GO:0050896 | response to stimulus | 1 | 11 |
GO:0051716 | cellular response to stimulus | 2 | 11 |
GO:0051726 | regulation of cell cycle | 4 | 11 |
GO:0065007 | biological regulation | 1 | 11 |
GO:0071704 | organic substance metabolic process | 2 | 11 |
GO:0090304 | nucleic acid metabolic process | 4 | 11 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 11 |
GO:1901987 | regulation of cell cycle phase transition | 6 | 11 |
GO:1901988 | negative regulation of cell cycle phase transition | 7 | 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 1 |
GO:0004518 | nuclease activity | 4 | 1 |
GO:0004527 | exonuclease activity | 5 | 1 |
GO:0004529 | DNA exonuclease activity | 5 | 1 |
GO:0004536 | DNA nuclease activity | 4 | 1 |
GO:0008853 | obsolete exodeoxyribonuclease III activity | 7 | 1 |
GO:0016787 | hydrolase activity | 2 | 1 |
GO:0016788 | hydrolase activity, acting on ester bonds | 3 | 1 |
GO:0016796 | exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 6 | 1 |
GO:0016895 | DNA exonuclease activity, producing 5'-phosphomonoesters | 6 | 1 |
GO:0140097 | catalytic activity, acting on DNA | 3 | 1 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 275 | 279 | PF00656 | 0.700 |
CLV_C14_Caspase3-7 | 75 | 79 | PF00656 | 0.311 |
CLV_MEL_PAP_1 | 148 | 154 | PF00089 | 0.357 |
CLV_PCSK_SKI1_1 | 56 | 60 | PF00082 | 0.322 |
CLV_PCSK_SKI1_1 | 68 | 72 | PF00082 | 0.267 |
CLV_PCSK_SKI1_1 | 93 | 97 | PF00082 | 0.414 |
DEG_APCC_DBOX_1 | 143 | 151 | PF00400 | 0.355 |
DOC_ANK_TNKS_1 | 264 | 271 | PF00023 | 0.516 |
DOC_CYCLIN_RxL_1 | 53 | 61 | PF00134 | 0.357 |
DOC_MAPK_gen_1 | 141 | 150 | PF00069 | 0.298 |
DOC_MAPK_HePTP_8 | 183 | 195 | PF00069 | 0.355 |
DOC_MAPK_MEF2A_6 | 144 | 152 | PF00069 | 0.297 |
DOC_MAPK_MEF2A_6 | 186 | 195 | PF00069 | 0.355 |
DOC_MAPK_MEF2A_6 | 335 | 343 | PF00069 | 0.448 |
DOC_MAPK_MEF2A_6 | 6 | 14 | PF00069 | 0.345 |
DOC_PP2B_LxvP_1 | 71 | 74 | PF13499 | 0.386 |
DOC_USP7_MATH_1 | 298 | 302 | PF00917 | 0.652 |
DOC_USP7_MATH_1 | 349 | 353 | PF00917 | 0.528 |
DOC_USP7_MATH_1 | 88 | 92 | PF00917 | 0.355 |
DOC_WW_Pin1_4 | 107 | 112 | PF00397 | 0.410 |
DOC_WW_Pin1_4 | 117 | 122 | PF00397 | 0.410 |
DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.465 |
LIG_14-3-3_CanoR_1 | 132 | 138 | PF00244 | 0.410 |
LIG_14-3-3_CanoR_1 | 15 | 21 | PF00244 | 0.410 |
LIG_14-3-3_CanoR_1 | 151 | 158 | PF00244 | 0.410 |
LIG_14-3-3_CanoR_1 | 223 | 230 | PF00244 | 0.333 |
LIG_14-3-3_CanoR_1 | 280 | 289 | PF00244 | 0.606 |
LIG_14-3-3_CanoR_1 | 317 | 321 | PF00244 | 0.392 |
LIG_14-3-3_CanoR_1 | 326 | 331 | PF00244 | 0.307 |
LIG_Actin_WH2_2 | 136 | 153 | PF00022 | 0.410 |
LIG_Actin_WH2_2 | 324 | 342 | PF00022 | 0.316 |
LIG_APCC_ABBA_1 | 37 | 42 | PF00400 | 0.297 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.358 |
LIG_deltaCOP1_diTrp_1 | 25 | 32 | PF00928 | 0.279 |
LIG_FHA_1 | 138 | 144 | PF00498 | 0.297 |
LIG_FHA_1 | 17 | 23 | PF00498 | 0.373 |
LIG_FHA_1 | 229 | 235 | PF00498 | 0.361 |
LIG_FHA_1 | 282 | 288 | PF00498 | 0.421 |
LIG_FHA_1 | 317 | 323 | PF00498 | 0.451 |
LIG_FHA_1 | 342 | 348 | PF00498 | 0.369 |
LIG_FHA_1 | 49 | 55 | PF00498 | 0.337 |
LIG_FHA_1 | 90 | 96 | PF00498 | 0.343 |
LIG_FHA_2 | 108 | 114 | PF00498 | 0.297 |
LIG_FHA_2 | 120 | 126 | PF00498 | 0.150 |
LIG_FHA_2 | 73 | 79 | PF00498 | 0.322 |
LIG_LIR_Gen_1 | 2 | 12 | PF02991 | 0.342 |
LIG_LIR_Gen_1 | 25 | 32 | PF02991 | 0.279 |
LIG_LIR_Gen_1 | 284 | 293 | PF02991 | 0.667 |
LIG_LIR_Gen_1 | 351 | 357 | PF02991 | 0.595 |
LIG_LIR_Gen_1 | 61 | 70 | PF02991 | 0.410 |
LIG_LIR_Nem_3 | 2 | 7 | PF02991 | 0.332 |
LIG_LIR_Nem_3 | 25 | 30 | PF02991 | 0.279 |
LIG_LIR_Nem_3 | 310 | 315 | PF02991 | 0.445 |
LIG_LIR_Nem_3 | 351 | 357 | PF02991 | 0.595 |
LIG_LIR_Nem_3 | 61 | 65 | PF02991 | 0.346 |
LIG_NRBOX | 133 | 139 | PF00104 | 0.410 |
LIG_NRBOX | 190 | 196 | PF00104 | 0.197 |
LIG_PDZ_Class_3 | 352 | 357 | PF00595 | 0.611 |
LIG_PTB_Apo_2 | 280 | 287 | PF02174 | 0.574 |
LIG_PTB_Phospho_1 | 280 | 286 | PF10480 | 0.576 |
LIG_SH2_CRK | 4 | 8 | PF00017 | 0.344 |
LIG_SH2_NCK_1 | 62 | 66 | PF00017 | 0.410 |
LIG_SH2_STAP1 | 230 | 234 | PF00017 | 0.483 |
LIG_SH2_STAT5 | 230 | 233 | PF00017 | 0.488 |
LIG_SH2_STAT5 | 286 | 289 | PF00017 | 0.679 |
LIG_SH2_STAT5 | 4 | 7 | PF00017 | 0.322 |
LIG_SH3_3 | 343 | 349 | PF00018 | 0.357 |
LIG_SUMO_SIM_anti_2 | 342 | 347 | PF11976 | 0.406 |
LIG_SUMO_SIM_par_1 | 105 | 110 | PF11976 | 0.279 |
LIG_SUMO_SIM_par_1 | 18 | 23 | PF11976 | 0.322 |
LIG_SUMO_SIM_par_1 | 213 | 220 | PF11976 | 0.408 |
MOD_CDK_SPxxK_3 | 107 | 114 | PF00069 | 0.355 |
MOD_CK1_1 | 224 | 230 | PF00069 | 0.330 |
MOD_CK1_1 | 251 | 257 | PF00069 | 0.747 |
MOD_CK1_1 | 86 | 92 | PF00069 | 0.373 |
MOD_GlcNHglycan | 222 | 226 | PF01048 | 0.365 |
MOD_GlcNHglycan | 250 | 253 | PF01048 | 0.675 |
MOD_GlcNHglycan | 293 | 296 | PF01048 | 0.720 |
MOD_GlcNHglycan | 300 | 303 | PF01048 | 0.491 |
MOD_GSK3_1 | 117 | 124 | PF00069 | 0.322 |
MOD_GSK3_1 | 133 | 140 | PF00069 | 0.313 |
MOD_GSK3_1 | 16 | 23 | PF00069 | 0.338 |
MOD_GSK3_1 | 217 | 224 | PF00069 | 0.322 |
MOD_GSK3_1 | 247 | 254 | PF00069 | 0.755 |
MOD_GSK3_1 | 26 | 33 | PF00069 | 0.251 |
MOD_GSK3_1 | 46 | 53 | PF00069 | 0.150 |
MOD_N-GLC_1 | 46 | 51 | PF02516 | 0.410 |
MOD_NEK2_1 | 133 | 138 | PF00069 | 0.302 |
MOD_NEK2_1 | 264 | 269 | PF00069 | 0.803 |
MOD_NEK2_1 | 291 | 296 | PF00069 | 0.613 |
MOD_NEK2_1 | 32 | 37 | PF00069 | 0.355 |
MOD_NEK2_1 | 339 | 344 | PF00069 | 0.298 |
MOD_NEK2_1 | 48 | 53 | PF00069 | 0.322 |
MOD_NEK2_2 | 307 | 312 | PF00069 | 0.590 |
MOD_NEK2_2 | 349 | 354 | PF00069 | 0.515 |
MOD_PK_1 | 326 | 332 | PF00069 | 0.363 |
MOD_PKA_2 | 150 | 156 | PF00069 | 0.355 |
MOD_PKA_2 | 264 | 270 | PF00069 | 0.781 |
MOD_PKA_2 | 279 | 285 | PF00069 | 0.670 |
MOD_PKA_2 | 316 | 322 | PF00069 | 0.457 |
MOD_PKB_1 | 221 | 229 | PF00069 | 0.197 |
MOD_Plk_1 | 181 | 187 | PF00069 | 0.410 |
MOD_Plk_4 | 133 | 139 | PF00069 | 0.360 |
MOD_Plk_4 | 26 | 32 | PF00069 | 0.318 |
MOD_Plk_4 | 307 | 313 | PF00069 | 0.581 |
MOD_Plk_4 | 326 | 332 | PF00069 | 0.357 |
MOD_Plk_4 | 341 | 347 | PF00069 | 0.378 |
MOD_Plk_4 | 349 | 355 | PF00069 | 0.519 |
MOD_Plk_4 | 72 | 78 | PF00069 | 0.484 |
MOD_ProDKin_1 | 107 | 113 | PF00069 | 0.410 |
MOD_ProDKin_1 | 117 | 123 | PF00069 | 0.410 |
MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.463 |
MOD_SUMO_rev_2 | 101 | 106 | PF00179 | 0.436 |
MOD_SUMO_rev_2 | 182 | 191 | PF00179 | 0.355 |
MOD_SUMO_rev_2 | 336 | 342 | PF00179 | 0.566 |
TRG_ENDOCYTIC_2 | 202 | 205 | PF00928 | 0.322 |
TRG_ENDOCYTIC_2 | 286 | 289 | PF00928 | 0.667 |
TRG_ENDOCYTIC_2 | 354 | 357 | PF00928 | 0.606 |
TRG_ENDOCYTIC_2 | 4 | 7 | PF00928 | 0.322 |
TRG_ENDOCYTIC_2 | 62 | 65 | PF00928 | 0.410 |
TRG_Pf-PMV_PEXEL_1 | 104 | 108 | PF00026 | 0.279 |
TRG_Pf-PMV_PEXEL_1 | 169 | 174 | PF00026 | 0.410 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HUB9 | Leptomonas seymouri | 70% | 100% |
A0A1X0NWX4 | Trypanosomatidae | 46% | 100% |
A0A3S7WVU5 | Leishmania donovani | 86% | 99% |
A0A422NCM6 | Trypanosoma rangeli | 45% | 100% |
A4HYN1 | Leishmania infantum | 91% | 100% |
C9ZI59 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 39% | 100% |
E9AUI3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 97% |
Q4QD01 | Leishmania major | 87% | 99% |
V5BVI1 | Trypanosoma cruzi | 44% | 100% |